Department of Mental Health, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Libyan J Med. 2009 Sep 1;4(3):114-6.
The aim of this study was to find out if the frequency of dream recall among neuropsychiatric patients on psychotropic drugs was significantly different from that of healthy individuals.
The study was done on 53 neuropsychiatric patients with different diagnoses who were on medication and 144 healthy individuals. The number of participants in each group who recalled their dreams and those who did not were compared and analyzed statistically for any significant difference.
Thirty-five out of the 53 neuropsychiatric patients and 133 out of the 144 healthy individuals were able to recall their dreams. A significantly (p < 0.001) higher proportion of the healthy individuals compared to neuropsychiatric patients on medications were able to recall their dreams.
This study has shown that neuropsychiatric patients on medications may have reduced dream episodes or that their ability to remember their dreams may be impaired. A combination of both factors is not unlikely. Thus, the patients have reduced dream recall frequency (DRF) compared to healthy subjects. There might also be individuals who do not dream.
本研究旨在探讨服用精神药物的神经精神科患者的梦境回忆频率是否与健康个体有显著差异。
该研究纳入了 53 名正在服用药物的不同诊断的神经精神科患者和 144 名健康个体。比较了每组中回忆梦境和未回忆梦境的参与者人数,并进行了统计学分析,以确定是否存在显著差异。
53 名神经精神科患者中有 35 名,144 名健康个体中有 133 名能够回忆起自己的梦境。与服用药物的神经精神科患者相比,健康个体能够回忆起梦境的比例显著更高(p<0.001)。
本研究表明,服用精神药物的神经精神科患者可能梦境减少,或者他们回忆梦境的能力受损。两种因素的结合并非不可能。因此,与健康受试者相比,患者的梦境回忆频率(DRF)降低。也可能存在不做梦的个体。